Current Challenges and Future Perspectives of Diagnosis of Hepatitis B Virus
Diagnostics · 19.01.2023 · 13 (3) · 368
DOI: 10.3390/diagnostics13030368 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 19.01.2023. Verfasst von Manoj Kumar und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Biologicals, Noida 201309, India. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
It is estimated that approximately 260 million people worldwide are infected with the hepatitis B virus (HBV), which is one of the leading causes of liver disease and liver cancer throughout the world. Compared with developed countries, low-income and middle-income countries have limited access to resources and advanced technologies that require highly specialized staff for HBV diagnosis. In spite of the heavy burden caused by hepatitis B virus, 90% of people are still undiagnosed. The World Health Organization (WHO) goal of eliminating hepatitis B by 2030 seems very difficult to achieve due to the existing diagnostic infrastructure in low-resource regions. The majority of diagnostic laboratories still use hepatitis B surface antigen (HBsAg)-based tests. WHO’s elimination plan is at risk of derailment due to phases like the window period, immune control, and occult HBV infection (OBI) not being detected by standard tests. Here, in this article, we are focusing on various diagnostic platforms for the better diagnosis of HBV. The aim of the elimination of HBV can only be achieved by detecting all phases of HBV infection, which can be executed by a combined approach of using new marker assays along with advanced pretesting and testing methods.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Institute of Biologicals, Noida 201309, India.
- Department of Immunohaematology and Blood Transfusion, Lady Hardinge Medical College and Associated Hospitals, New Delhi 110001, India.
- Center for Advanced Biotechnology Research, Xenesis Institute, 5th Floor, Plot 68, Sector 44, Gurugram 122003, India.
ORCID-Profile: Anoop Kumar
Zitieren
APA
Kumar, M., Pahuja, S., Khare, P., & Kumar, A. (2023). Current Challenges and Future Perspectives of Diagnosis of Hepatitis B Virus. Diagnostics, 13(3), 368. https://doi.org/10.3390/diagnostics13030368
Vancouver
Kumar M, Pahuja S, Khare P, Kumar A. Current Challenges and Future Perspectives of Diagnosis of Hepatitis B Virus. Diagnostics. 2023;13(3):368. doi:10.3390/diagnostics13030368
BibTeX
@article{Kumar2023,
author = {Kumar, Manoj and Pahuja, Sangeeta and Khare, Prashant and Kumar, Anoop},
title = {Current Challenges and Future Perspectives of Diagnosis of Hepatitis B Virus},
journal = {Diagnostics},
year = {2023},
volume = {13},
number = {3},
pages = {368},
doi = {10.3390/diagnostics13030368}
}
EUVIMED